文献速递甲状腺疾病

亚临床甲状腺功能减退症作为左心室血栓患者心血管预后独立预测因素

Subclinical Hypothyroidism as an Independent Predictor of Cardiovascular Prognosis in Left Ventricular Thrombus Patients.
PubMed 文献 · J Clin Endocrinol Metab · 2025-01-01

本研究基于阜外医院近10年左心室血栓(LVT)患者的回顾性数据,采用多变量Cox比例风险模型评估甲状腺功能状态与预后的关系。结果显示亚临床甲状腺功能减退症与主要不良心脑血管事件(MACCEs)发生率升高显著相关(HR 1.774,95%CI 1.053-2.989,P=.031),与心血管死亡也显著相关(HR 1.986,95%CI 1.110-3.553,P=.021),而亚临床甲状腺功能亢进组无显著相关性。将甲状腺功能纳入LVT预后评估可改善MACCEs的预测效果(1年AUC 0.715,2年AUC 0.745,3年AUC 0.684)。

要点

  • 亚临床甲状腺功能减退症是LVT患者MACCEs的独立预测因素(HR 1.774,95%CI 1.053-2.989,P=.031)。
  • 亚临床甲状腺功能减退症与LVT患者心血管死亡显著相关(HR 1.986,95%CI 1.110-3.553,P=.021)。
  • 亚临床甲状腺功能亢进组与LVT预后无显著相关性。

核心结论

  • 亚临床甲状腺功能减退症可作为LVT患者MACCEs的独立预测因素,将亚临床甲状腺功能减退症作为提示LVT患者预后不良的重要因素具有临床价值。

研究设计与样本

  • 回顾性研究,使用阜外医院近10年诊断为LVT的患者数据。

主要发现

  • 亚临床甲状腺功能减退症与LVT患者MACCEs发生率升高显著相关(HR 1.774,95%CI 1.053-2.989,P=.031)。
  • 亚临床甲状腺功能减退症与LVT患者心血管死亡显著相关(HR 1.986,95%CI 1.110-3.553,P=.021)。
  • 亚临床甲状腺功能亢进组与LVT预后无显著相关性。
  • 将甲状腺功能纳入LVT患者预后评估对MACCEs的预测效果:1年AUC 0.715,2年AUC 0.745,3年AUC 0.684。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVES: Left ventricular thrombus (LVT) is associated with an increased risk of adverse cardiovascular events, and thyroid hormones are known to affect the cardiovascular system in various ways. However, subclinical thyroid dysfunction still deserves to be emphasized, and its impact on the prognosis of patients with LVT is rare but needs to be investigated. METHODS: We used retrospective data from patients diagnosed with LVT at Fuwai Hospital over the past 10 years to assess the relationship between thyroid functional status and prognosis of LVT using multivariate Cox proportional hazards models and validated the improved predictive effect of including thyroid function in the prognostic assessment of LVT using receiver operating characteristic curves. RESULTS: Subclinical hypothyroidism was significantly associated with a higher incidence of major adverse cardiovascular and cerebrovascular events (MACCEs) [hazard ratio (HR) 1.774, 95% confidence interval (CI): 1.053-2.989; P = .031] and cardiovascular death (HR 1.986, 95% CI: 1.110-3.553; P = .021) in LVT patients, whereas no significant correlation was observed in the subclinical hyperthyroidism group. In addition, including thyroid function in the prognostic consideration of LVT patients would contribute to the predictive effect of MACCEs [area under the curve (AUC) for 1 year: 0.715; AUC for 2 years: 0.745; AUC for 3 years: 0.684]. CONCLUSION: Subclinical hypothyroidism can be used as an independent predictor of MACCEs in patients with LVT, and there is a clinical value in using subclinical hypothyroidism as an important factor suggesting a poor prognosis in patients with LVT.

来源:J Clin Endocrinol Metab,查看原文。版权归原作者所有。

引用

  1. Shi B, Liu Z, Zhang R, et al. Subclinical Hypothyroidism as an Independent Predictor of Cardiovascular Prognosis in Left Ventricular Thrombus Patients. J Clin Endocrinol Metab. 2025. PMID: 39527050. doi:10.1210/clinem/dgae793

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。